<SEC-DOCUMENT>0001193125-26-253436.txt : 20260602
<SEC-HEADER>0001193125-26-253436.hdr.sgml : 20260602
<ACCEPTANCE-DATETIME>20260602160114
ACCESSION NUMBER:		0001193125-26-253436
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		12
CONFORMED PERIOD OF REPORT:	20260529
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260602
DATE AS OF CHANGE:		20260602

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Forte Biosciences, Inc.
		CENTRAL INDEX KEY:			0001419041
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				261243872
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38052
		FILM NUMBER:		261055756

	BUSINESS ADDRESS:	
		STREET 1:		3060 PEGASUS PARK DRIVE
		STREET 2:		BUILDING 6
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75247
		BUSINESS PHONE:		(310) 618-6994

	MAIL ADDRESS:	
		STREET 1:		3060 PEGASUS PARK DRIVE
		STREET 2:		BUILDING 6
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75247

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tocagen Inc
		DATE OF NAME CHANGE:	20071120
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d110060d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:fbrx="http://www.fortebiorx.com/20260529" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-486">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2026-05-29_to_2026-05-29">0001419041</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="fbrx-20260529.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2026-05-29_to_2026-05-29"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001419041</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-05-29</xbrli:startDate> <xbrli:endDate>2026-05-29</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-497">8-K</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt:datemonthdayyearen" id="ixv-498">May 29, 2026</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-499">FORTE BIOSCIENCES, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in Its Charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt-sec:stateprovnameen" id="ixv-500">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-501">001-38052</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-502">26-1243872</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-503">3060 Pegasus Park Dr.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-504">Building 6</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-505">Dallas</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt-sec:stateprovnameen" id="ixv-506">Texas</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-507">75247</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-508">(310)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-509">618-6994</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt-sec:boolballotbox" id="ixv-510">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt-sec:boolballotbox" id="ixv-511">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt-sec:boolballotbox" id="ixv-512">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt-sec:boolballotbox" id="ixv-513">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-514">Common Stock, $0.001 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-515">FBRX</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt-sec:exchnameen" id="ixv-516">The NASDAQ Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;&#8201;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt-sec:boolballotbox" id="ixv-517">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;5.02.</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The board of directors of Forte Biosciences, Inc. (the &#8220;Company&#8221;) previously approved the amendment and restatement of the Company&#8217;s 2021 Equity Incentive Plan (the &#8220;2021 Equity Incentive Plan&#8221;) at the Company&#8217;s 2021 annual meeting of stockholders, and in connection with the special meeting of stockholders held on January&#160;24, 2025 (the &#8220;2025 Special Meeting&#8221;). Most recently, at the Annual Meeting (as defined in Item 5.07 below), the Company&#8217;s stockholders approved the further amendment and restatement of the 2021 Equity Incentive Plan (as currently amended and restated, the &#8220;A&amp;R 2021 Equity Incentive Plan&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purposes of the A&amp;R 2021 Equity Incentive Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentives to employees, directors and consultants, and to promote the success of the Company&#8217;s business. These purposes are achieved through the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, performance units, and performance shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The number of shares of common stock of the Company (the &#8220;Shares&#8221;) reserved for issuance under the A&amp;R 2021 Equity Incentive Plan is equal to the sum of: (a) 5,190,000, representing 3,340,000 Shares approved in connection with the 2025 Special Meeting and 1,850,000 newly requested Shares, plus (b)&#160;any Shares subject to awards granted under the Tocagen, Inc. 2009 Equity Incentive Plan, the Tocagen, Inc. 2017 Equity Incentive Plan, and the Forte Biosciences Inc. 2018 Equity Incentive Plan that, after May&#160;28, 2021, the date of the original stockholder approval of the 2021 Equity Incentive Plan, expire or otherwise terminate without having been exercised or issued in full, are forfeited to or repurchased by the Company due to failure to vest, or are used to pay the exercise price of such awards or to satisfy the tax liabilities or withholdings related to such awards. The maximum number of Shares to be added to the A&amp;R 2021 Equity Incentive Plan pursuant to clause (b)&#160;is equal to 44,093 Shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The material terms of the A&amp;R 2021 Equity Incentive Plan are described in &#8220;Proposal No.&#160;4 - Approval of the Amended and Restated 2021 Equity Incentive Plan&#8221; in the Company&#8217;s definitive proxy statement on Schedule 14A filed with the United States Securities and Exchange Commission on April&#160;29, 2026, which description is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the A&amp;R 2021 Equity Incentive Plan is qualified in its entirety by reference to the text of the A&amp;R 2021 Equity Incentive Plan, which is filed as Exhibit 10.1 to this Current Report on <span style="white-space:nowrap">Form&#160;8-K&#160;and</span> incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;5.07.</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Submission of Matters to a Vote of Security Holders. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company held its 2026 annual meeting of stockholders on May&#160;29, 2026 (the &#8220;Annual Meeting&#8221;). Of the 20,478,817 Shares outstanding as of the record date of April&#160;17, 2026, 17,766,034 Shares were represented at the Annual Meeting, either by proxy or by attending the meeting. The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><span style="font-weight:bold">1.</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">Election of Class</span><span style="font-weight:bold"></span><span style="font-weight:bold">&#160;III Directors. </span>The following nominees were elected to serve as Class&#160;III directors, each to hold office until the Company&#8217;s 2029 annual meeting of stockholders or until his respective successor has been duly elected and qualified or his or her earlier resignation or removal: </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:60%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">Nominee</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Votes For</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Votes&#160;Withheld</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap">Broker&#160;Non-Votes</span></span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven Kornfeld</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,286,043</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,973,928</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,506,063</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Brun, M.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,958,889</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,301,082</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,506,063</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paul A. Wagner, Ph.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">16,027,110</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">232,861</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,506,063</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><span style="font-weight:bold">2.</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">Ratification of Appointment of Independent Registered Public Accounting Firm.</span> The appointment of KPMG LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December&#160;31, 2026 was ratified based on the following results of voting: </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Votes For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Votes Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstentions</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;text-align:center">17,722,893</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center">3,182</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center">39,959</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">0</p></td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><span style="font-weight:bold">3.</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">Advisory Vote on Executive</span><span style="font-weight:bold"></span><span style="font-weight:bold">&#160;Compensation.</span> The Company&#8217;s stockholders approved, on an advisory basis, the compensation of the Company&#8217;s named executive officers for the fiscal year ended December&#160;31, 2025. The votes regarding the proposal were as follows: </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Votes For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Votes Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstentions</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;text-align:center">12,143,153</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center">3,764,729</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center">352,089</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center">1,506,063</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><span style="font-weight:bold">4.</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">Approval of the Amended and Restated </span><span style="font-weight:bold">2021 Equity Incentive Plan</span><span style="font-weight:bold">. </span>The Company&#8217;s stockholders approved the A&amp;R 2021 Equity Incentive Plan. The votes regarding the proposal were as follows: </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Votes For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Votes Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstentions</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;text-align:center">11,911,879</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center">3,997,050</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center">351,042</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center">1,506,063</td></tr>
</table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) &#8195;Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"></span>Exhibit<span style="font-weight:bold"></span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d110060dex101.htm">Amended and Restated 2021 Equity Incentive Plan</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The cover page of this Current Report on <span style="white-space:nowrap">Form&#160;8-K,&#160;formatted</span> in inline XBRL.</td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">FORTE BIOSCIENCES, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: June&#160;2, 2026</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Antony Riley</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Antony Riley</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d110060dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORTE BIOSCIENCES, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED 2021 EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Adopted and Approved Effective April&nbsp;28, 2026) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Purposes of the Plan</U>. The purposes of this Plan are: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to attract and retain the best available personnel for positions of substantial responsibility,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to provide additional incentive to Employees, Directors and Consultants, and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to promote the success of the Company&#8217;s business. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Plan permits the grant of Incentive Stock Options, Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted
Stock Units and Performance Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Definitions</U>. As used herein, the following definitions will apply: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.1 &#8220;<U>Administrator</U>&#8221; means the Board or any of its Committees as will be administering the Plan, in accordance with
Section&nbsp;4 of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.2 &#8220;<U>Applicable Laws</U>&#8221; means the legal and regulatory requirements relating to the
administration of equity-based awards, including but not limited to the related issuance of shares of Common Stock, including but not limited to, under U.S. federal and state corporate laws, U.S. federal and state securities laws, the Code, any
stock exchange or quotation system on which the Common Stock is listed or quoted and the applicable laws of any <FONT STYLE="white-space:nowrap">non-U.S.</FONT> country or jurisdiction where Awards are, or will be, granted under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.3 &#8220;<U>Award</U>&#8221; means, individually or collectively, a grant under the Plan of Options, Stock Appreciation Rights, Restricted
Stock, Restricted Stock Units, or Performance Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4 &#8220;<U>Award Agreement</U>&#8221; means the written or electronic agreement
setting forth the terms and provisions applicable to each Award granted under the Plan. The Award Agreement is subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.5 &#8220;<U>Board</U>&#8221; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.6 &#8220;<U>Change in Control</U>&#8221; means the occurrence of any of the following events: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Change in Ownership of the Company</U>. A change in the ownership of the Company<I> </I>which occurs on the date that any one person,
or more than one person acting as a group (&#8220;<U>Person</U>&#8221;), acquires ownership of the stock of the Company that, together with the stock held by such Person, constitutes more than fifty percent (50%)&nbsp;of the total voting power of
the stock of the Company; provided, however, that for purposes of this subsection&nbsp;(a), the acquisition </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of additional stock by any one Person, who is considered to own more than fifty percent (50%)&nbsp;of the total voting power of the stock of the Company will not be considered a Change in
Control; provided, further, that any change in the ownership of the stock of the Company as a result of a private financing of the Company that is approved by the Board also will not be considered a Change in Control. Further, if the stockholders of
the Company immediately before such change in ownership continue to retain immediately after the change in ownership, in substantially the same proportions as their ownership of shares of the Company&#8217;s voting stock immediately prior to the
change in ownership, direct or indirect beneficial ownership of fifty percent (50%) or more of the total voting power of the stock of the Company or of the ultimate parent entity of the Company, such event will not be considered a Change in Control
under this subsection (a). For this purpose, indirect beneficial ownership will include, without limitation, an interest resulting from ownership of the voting securities of one or more corporations or other business entities which own the Company,
as the case may be, either directly or through one or more subsidiary corporations or other business entities; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Change in
Effective Control of the Company</U>. If the Company has a class of securities registered pursuant to Section&nbsp;12 of the Exchange Act, a change in the effective control of the Company which occurs on the date that a majority of members of the
Board is replaced during any twelve (12)&nbsp;month period by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purposes of this subsection (b), if
any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Change in Control; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Change in Ownership of a Substantial Portion of the Company</U><U>&#8217;</U><U>s Assets</U>. A change in the ownership of a
substantial portion of the Company&#8217;s assets which occurs on the date that any Person acquires (or has acquired during the twelve (12)&nbsp;month period ending on the date of the most recent acquisition by such Person or Persons)&nbsp;assets
from the Company that have a total gross fair market value equal to or more than fifty percent (50%)&nbsp;of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions; provided,
however, that for purposes of this subsection (c), the following will not constitute a change in the ownership of a substantial portion of the Company&#8217;s assets: (i)&nbsp;a transfer to an entity that is controlled by the Company&#8217;s
stockholders immediately after the transfer, or (ii)&nbsp;a transfer of assets by the Company to: (A)&nbsp;a stockholder of the Company (immediately before the asset transfer)&nbsp;in exchange for or with respect to the Company&#8217;s stock,
(B)&nbsp;an entity, fifty percent (50%)&nbsp;or more of the total value or voting power of which is owned, directly or indirectly, by the Company, (C)&nbsp;a Person, that owns, directly or indirectly, fifty percent (50%)&nbsp;or more of the total
value or voting power of all the outstanding stock of the Company, or (D)&nbsp;an entity, at least fifty percent (50%)&nbsp;of the total value or voting power of which is owned, directly or indirectly, by a Person described in this subsection
(c)(ii)(C). For purposes of this subsection (c), gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">For purposes of this Section&nbsp;2.6, persons will be considered to be acting as a group if they are owners of a corporation that enters
into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed a Change in Control unless
the transaction qualifies as a change in control event within the meaning of Code Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Further and for the avoidance of
doubt, a transaction will not constitute a Change in Control if: (x)&nbsp;its sole purpose is to change the jurisdiction of the Company&#8217;s incorporation, or (y)&nbsp;its sole purpose is to create a holding company that will be owned in
substantially the same proportions by the persons who held the Company&#8217;s securities immediately before such transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.7
&#8220;<U>Code</U>&#8221; means the U.S. Internal Revenue Code of 1986, as amended. Reference to a specific section of the Code or regulation thereunder will include such section or regulation, any valid regulation or other formal guidance of
general or direct applicability promulgated under such section, and any comparable provision of any future legislation or regulation amending, supplementing or superseding such section or regulation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.8 &#8220;<U>Committee</U>&#8221; means a committee of Directors or of other individuals satisfying Applicable Laws appointed by the Board,
or by a duly authorized committee of the Board, in accordance with Section&nbsp;4 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.9 &#8220;<U>Common Stock</U>&#8221; means the
common stock of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.10 &#8220;<U>Company</U>&#8221; means Forte Biosciences, Inc., a<B> </B>Delaware corporation, or any
successor thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.11 &#8220;<U>Consultant</U>&#8221; means any natural person, including an advisor, engaged by the Company or any of
its Parent or Subsidiaries to render bona fide services to such entity, provided the services (a)&nbsp;are not in connection with the offer or sale of securities in a capital-raising transaction, and (b)&nbsp;do not directly promote or maintain a
market for the Company&#8217;s securities, in each case, within the meaning of Form <FONT STYLE="white-space:nowrap">S-8</FONT> promulgated under the Securities Act, and provided further, that a Consultant will include only those persons to whom the
issuance of Shares may be registered under Form <FONT STYLE="white-space:nowrap">S-8</FONT> promulgated under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.12
&#8220;<U>Director</U>&#8221; means a member of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.13 &#8220;<U>Disability</U>&#8221; means total and permanent disability as
defined in Code Section&nbsp;22(e)(3), provided that in the case of Awards other than Incentive Stock Options, the Administrator in its discretion may determine whether a permanent and total disability exists in accordance with uniform and <FONT
STYLE="white-space:nowrap">non-discriminatory</FONT> standards adopted by the Administrator from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.14
&#8220;<U>Employee</U>&#8221; means any person, including Officers and Directors, employed by the Company or any Parent or Subsidiary of the Company. Neither service as a Director nor payment of a director&#8217;s fee by the Company will be
sufficient to constitute &#8220;employment&#8221; by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.15 &#8220;<U>Exchange Act</U>&#8221; means the U.S. Securities
Exchange Act of 1934, as amended, including the rules and regulations promulgated thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.16 &#8220;<U>Exchange Program</U>&#8221; means a program under which (a)&nbsp;outstanding
Awards are surrendered or cancelled in exchange for awards of the same type (which may have higher or lower exercise prices and different terms), awards of a different type, and/or cash, (b)&nbsp;Participants would have the opportunity to transfer
any outstanding Awards to a financial institution or other person or entity selected by the Administrator, and/or (c)&nbsp;the exercise price of an outstanding Award is reduced or increased. The Administrator will determine the terms and conditions
of any Exchange Program in its sole discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.17 &#8220;<U>Fair Market Value</U>&#8221; means, as of any date and unless the
Administrator determines otherwise, the value of Common Stock determined as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">2.17.1 If the Common Stock is listed on any
established stock exchange or a national market system, including without limitation the New York Stock Exchange or the Nasdaq Global Select Market, the Nasdaq Global Market, or the Nasdaq Capital Market of The Nasdaq Stock Market, its Fair Market
Value will be the closing sales price for such stock (or, if no closing sales price was reported on that date, as applicable, on the last Trading Day such closing sales price was reported) as quoted on such exchange or system on the date of
determination, as reported in <I>The Wall Street Journal</I> or such other source as the Administrator deems reliable; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">2.17.2 If the
Common Stock is regularly quoted by a recognized securities dealer but selling prices are not reported, the Fair Market Value of a Share will be the mean between the high bid and low asked prices for the Common Stock on the day of determination (or,
if no bids and asks were reported on that date, as applicable, on the last Trading Day such bids and asks were reported), as reported in <I>The Wall Street Journal</I> or such other source as the Administrator deems reliable; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">2.17.3 In the absence of an established market for the Common Stock, the Fair Market Value will be determined in good faith by the
Administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.18 &#8220;<U>Fiscal Year</U>&#8221; means the fiscal year of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.19 &#8220;<U>Incentive Stock Option</U>&#8221; means an Option that by its terms qualifies and is otherwise intended to qualify as an
incentive stock option within the meaning of Code Section&nbsp;422 and the regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.20
&#8220;<U>Nonstatutory Stock Option</U>&#8221; means an Option that by its terms does not qualify or is not intended to qualify as an Incentive Stock Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.21 &#8220;<U>Officer</U>&#8221; means a person who is an officer of the Company within the meaning of Section&nbsp;16 of the Exchange Act
and the rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.22 &#8220;<U>Option</U>&#8221; means a stock option granted pursuant to the Plan.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.23 &#8220;<U>Outside Director</U>&#8221; means a Director who is not an Employee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.24 &#8220;<U>Parent</U>&#8221; means a &#8220;parent corporation,&#8221; whether now or hereafter existing, as defined in Code
Section&nbsp;424(e). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.25 &#8220;<U>Participant</U>&#8221; means the holder of an outstanding Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.26 &#8220;<U>Performance Awards</U>&#8221; means an Award which may be earned in whole or in part upon attainment of performance goals or
other vesting criteria as the Administrator may determine and which may be cash- or stock-denominated and may be settled for cash, Shares or other securities or a combination of the foregoing under Section&nbsp;10. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.27 &#8220;<U>Performance Period</U>&#8221; means Performance Period as defined in Section&nbsp;10.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.28 &#8220;<U>Period of Restriction</U>&#8221; means the period (if any) during which the transfer of Shares of Restricted Stock are subject
to restrictions and therefore, the Shares are subject to a substantial risk of forfeiture. Such restrictions may be based on the passage of time, the achievement of target levels of performance, or the occurrence of other events as determined by the
Administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.29 &#8220;<U>Plan</U>&#8221; means this Amended and Restated 2021 Equity Incentive Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.30 &#8220;<U>Restricted Stock</U>&#8221; means Shares issued pursuant to an Award of Restricted Stock under Section&nbsp;8 of the Plan, or
issued pursuant to the early exercise of an Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.31 &#8220;<U>Restricted Stock Unit</U>&#8221; means a bookkeeping entry
representing an amount equal to the Fair Market Value of one Share, granted pursuant to Section&nbsp;9. Each Restricted Stock Unit represents an unfunded and unsecured obligation of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.32 &#8220;<U>Rule</U><U></U><U>&nbsp;16b</U><U><FONT STYLE="white-space:nowrap">-3</FONT></U>&#8221; means
<FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3</FONT> of the Exchange Act or any successor to <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3,</FONT> as in effect when discretion is being exercised with respect to the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.33 &#8220;<U>Section</U><U></U><U>&nbsp;16b</U>&#8221; means Section&nbsp;16(b) of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.34 &#8220;<U>Section</U><U></U><U>&nbsp;409A</U>&#8221; means Code Section&nbsp;409A and the U.S. Treasury Regulations and guidance
thereunder, and any applicable state law equivalent, as each may be promulgated, amended or modified from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.35
&#8220;<U>Securities Act</U>&#8221; means the U.S. Securities Act of 1933, as amended, including the rules and regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.36 &#8220;<U>Service Provider</U>&#8221; means an Employee, Director or Consultant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.37 &#8220;<U>Share</U>&#8221; means a share of the Common Stock, as adjusted in accordance with Section&nbsp;14 of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.38 &#8220;<U>Stock Appreciation Right</U>&#8221; means an Award, granted alone or in connection with an Option, that pursuant to
Section&nbsp;7 is designated as a Stock Appreciation Right. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.39 &#8220;<U>Subsidiary</U>&#8221; means a &#8220;subsidiary
corporation,&#8221; whether now or hereafter existing, as defined in Code Section&nbsp;424(f). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.40 &#8220;<U>Trading Day</U>&#8221; means a day that the primary stock exchange, national
market system, or other trading platform, as applicable, upon which the Common Stock is listed (or otherwise trades regularly, as determined by the Administrator, in its sole discretion) is open for trading. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.41 &#8220;<U>U.S. Treasury Regulations</U>&#8221; means the Treasury Regulations of the Code. Reference to a specific Treasury Regulation or
Section of the Code will include such Treasury Regulation or Section, any valid regulation promulgated under such Section, and any comparable provision of any future legislation or regulation amending, supplementing or superseding such Section or
regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Stock</U><U></U><U>&nbsp;Subject</U><U></U><U>&nbsp;to</U><U></U><U>&nbsp;the</U><U></U><U>&nbsp;Plan</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.1 <U>Stock Subject to the Plan</U>. Subject to adjustment upon changes in capitalization of the Company as provided in Section&nbsp;14, the
maximum aggregate number of Shares that may be subject to Awards and sold under the Plan will be equal to (a)&nbsp;5,190,000 Shares, plus (b)&nbsp;any Shares subject to awards granted under the Tocagen, Inc. 2009 Equity Incentive Plan, the Tocagen,
Inc. 2017 Equity Incentive Plan, and the Forte Biosciences Inc. 2018 Equity Incentive Plan that, after May&nbsp;28, 2021, the date of the original stockholder approval of the 2021 Equity Incentive Plan, expire or otherwise terminate without having
been exercised or issued in full, are forfeited to or repurchased by the Company due to failure to vest or are used to pay the exercise price of such awards or to satisfy the tax liabilities or withholdings related to such awards, with the maximum
number of Shares to be added to the Plan pursuant to clause&nbsp;(b) equal to 44,093. In addition, Shares may become available for issuance under Section&nbsp;3.2. The Shares may be authorized but unissued, or reacquired Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.2 <U>Lapsed Awards</U>. If an Award expires or becomes unexercisable without having been exercised in full, or, with respect to Restricted
Stock, Restricted Stock Units, Performance Units or Performance Shares is forfeited to or repurchased by the Company due to the failure to vest, the unpurchased Shares (or for Awards other than Options or Stock Appreciation Rights the forfeited or
repurchased Shares) which were subject thereto will become available for future grant or sale under the Plan (unless the Plan has terminated). Upon exercise of a Stock Appreciation Right settled in Shares, the gross number of Shares covered by the
portion of the Award so exercised, whether or not actually issued pursuant to such exercise, will cease to be available under the Plan. Shares that have actually been issued under the Plan under any Award will not be returned to the Plan and will
not become available for future distribution under the Plan; provided, however, that if Shares issued pursuant to Awards of Restricted Stock, Restricted Stock Units or Performance Awards are repurchased by the Company or are forfeited to the Company
due to the failure to vest, such Shares will become available for future grant under the Plan. Shares used to pay the exercise price of an Award or to satisfy the tax liabilities or withholdings related to an Award will become available for future
grant or sale under the Plan. To the extent an Award under the Plan is paid out in cash rather than Shares, such cash payment will not result in reducing the number of Shares available for issuance under the Plan. Notwithstanding the foregoing and,
subject to adjustment as provided in Section&nbsp;14, the maximum number of Shares that may be issued upon the exercise of Incentive Stock Options will equal the aggregate Share number stated in Section&nbsp;3.1, plus, to the extent allowable under
Code Section&nbsp;422 and the U.S. Treasury Regulations promulgated thereunder, any Shares that become available for issuance under the Plan pursuant to Section&nbsp;3.2. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.3 <U>Share Reserve</U>. The Company, during the term of this Plan, will at all times
reserve and keep available such number of Shares as will be sufficient to satisfy the requirements of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Administration of
the Plan</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.1 <U>Procedure</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.1.1 <U>Multiple Administrative Bodies</U>. Different Committees with respect to different groups of Service Providers may administer the
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.1.2 <U>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT></U>. To the extent desirable to qualify transactions hereunder as
exempt under <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3,</FONT> the transactions contemplated hereunder will be structured to satisfy the requirements for exemption under <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.1.3 <U>Other Administration</U>. Other than as provided above, the Plan will be administered by (A)&nbsp;the Board or (B)&nbsp;a Committee,
which Committee will be constituted to comply with Applicable Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.2 <U>Powers of the Administrator</U>. Subject to the provisions of
the Plan, and in the case of a Committee, subject to the specific duties delegated by the Board to such Committee, the Administrator will have the authority, in its discretion: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.2.1 to determine the Fair Market Value; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.2.2 to select the Service Providers to whom Awards may be granted hereunder; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.2.3 to determine the number of Shares to be covered by each Award granted hereunder; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.2.4 to approve forms of Award Agreements for use under the Plan; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.2.5 to determine the terms and conditions, not inconsistent with the terms of the Plan, of any Award granted hereunder. Such terms and
conditions include, but are not limited to, the exercise price, the time or times when Awards may be exercised (which may be based on performance criteria), any vesting acceleration or waiver of forfeiture restrictions, and any restriction or
limitation regarding any Award or the Shares relating thereto (including but not limited to, temporarily suspending the exercisability of an Award if the Administrator deems such suspension to be necessary or appropriate for administrative purposes
or to comply with Applicable Laws, provided that such suspension must be lifted prior to the expiration of the maximum term and post-termination exercisability period of an Award), based in each case on such factors as the Administrator will
determine; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.2.6 to construe and interpret the terms of the Plan and Awards granted pursuant to the
Plan; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.2.7 to prescribe, amend and rescind rules and regulations relating to the Plan, including rules and regulations relating to <FONT
STYLE="white-space:nowrap">sub-plans</FONT> established for the purpose of satisfying applicable <FONT STYLE="white-space:nowrap">non-U.S.</FONT> laws or for qualifying for favorable tax treatment under applicable
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> laws; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.2.8 to modify or amend each Award (subject to Section&nbsp;20.3), including but
not limited to the discretionary authority to extend the post-termination exercisability period of Awards and to extend the maximum term of an Option or Stock Appreciation Right (subject to Sections 6.4 and 7.5); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.2.9 to allow Participants to satisfy withholding tax obligations in a manner prescribed in Section&nbsp;15; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.2.10 to authorize any person to execute on behalf of the Company any instrument required to effect the grant of an Award previously granted
by the Administrator; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.2.11 to allow a Participant to defer the receipt of the payment of cash or the delivery of Shares that otherwise
would be due to such Participant under an Award; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.2.12 to make all other determinations deemed necessary or advisable for
administering the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.3 <U>Effect of Administrator&#8217;s</U><U></U><U>&nbsp;Decision</U>. The Administrator&#8217;s decisions,
determinations and interpretations will be final and binding on all Participants and any other holders of Awards and will be given the maximum deference permitted by Applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.4 <U>Exchange Program</U>. The Administrator may not institute an Exchange Program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Eligibility</U>. Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Shares and
Performance Units may be granted to Service Providers. Incentive Stock Options may be granted only to Employees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Stock Options</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.1 <U>Grant of Options</U>. Subject to the terms and provisions of the Plan, the Administrator, at any time and from time to time, may
grant Options to Service Providers in such amounts as the Administrator, in its sole discretion, will determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.2 <U>Option
Agreement</U>. Each Award of an Option will be evidenced by an Award Agreement that will specify the exercise price, the term of the Option, the number of Shares subject to the Option, the exercise restrictions, if any, applicable to the Option, and
such other terms and conditions as the Administrator, in its sole discretion, will determine. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-8- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.3 <U>Limitations</U>. Each Option will be designated in the Award Agreement as either an
Incentive Stock Option or a Nonstatutory Stock Option. Notwithstanding such designation, however, to the extent that the aggregate Fair Market Value of the Shares with respect to which Incentive Stock Options are exercisable for the first time by
the Participant during any calendar year (under all plans of the Company and any Parent or Subsidiary) exceeds one hundred thousand dollars ($100,000), such Options will be treated as Nonstatutory Stock Options. For purposes of this
Section&nbsp;6.3, Incentive Stock Options will be taken into account in the order in which they were granted, the Fair Market Value of the Shares will be determined as of the time the Option with respect to such Shares is granted, and calculation
will be performed in accordance with Code Section&nbsp;422 and the U.S. Treasury Regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.4 <U>Term of
Option</U>. The term of each Option will be stated in the Award Agreement; provided, however, that the term will be no more than ten (10)&nbsp;years from the date of grant thereof. In the case of an Incentive Stock Option granted to a Participant
who, at the time the Incentive Stock Option is granted, owns stock representing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or any Parent or Subsidiary, the term of the Incentive Stock Option
will be five (5)&nbsp;years from the date of grant or such shorter term as may be provided in the Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.5 <U>Option Exercise
Price and Consideration</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">6.5.1 <U>Exercise Price</U>. The per Share exercise price for the Shares to be issued pursuant to the
exercise of an Option will be determined by the Administrator, but will be no less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant. In addition, in the case of an Incentive Stock Option granted to an Employee
who owns stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company or any Parent or Subsidiary, the per Share exercise price will be no less than one hundred ten percent (110%) of the Fair Market Value
per Share on the date of grant. Notwithstanding the foregoing provisions of this Section&nbsp;6.5.1, Options may be granted with a per Share exercise price of less than one hundred percent (100%) of the Fair Market Value per Share on the date of
grant pursuant to a transaction described in, and in a manner consistent with, Code Section&nbsp;424(a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">6.5.2 <U>Waiting Period and
Exercise Dates</U>. At the time an Option is granted, the Administrator will fix the period within which the Option may be exercised and will determine any conditions that must be satisfied before the Option may be exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">6.5.3 <U>Form of Consideration</U>. The Administrator will determine the acceptable form of consideration for exercising an Option, including
the method of payment. In the case of an Incentive Stock Option, the Administrator will determine the acceptable form of consideration at the time of grant. Such consideration may consist entirely of: (a)&nbsp;cash (including cash equivalents); (b)
check; (c)&nbsp;promissory note, to the extent permitted by Applicable Laws, (d)&nbsp;other Shares, provided that such Shares have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which such
Option will be exercised and provided further that accepting such Shares will not result in any adverse accounting consequences to the Company, as the Administrator determines in its sole discretion; (e)&nbsp;consideration received by the Company
under a cashless exercise program (whether through a broker or otherwise) implemented by the Company in connection with the Plan; (f)&nbsp;by net exercise; (g)&nbsp;such other consideration and method of payment for the issuance of Shares to the
extent permitted by Applicable Laws, or (h)&nbsp;any combination of the foregoing methods of payment. In making its determination as to the type of consideration to accept, the Administrator will consider if acceptance of such consideration may be
reasonably expected to benefit the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-9- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.6 <U>Exercise of Option</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">6.6.1 <U>Procedure for Exercise; Rights as a Stockholder</U>. Any Option granted hereunder will be exercisable according to the terms of the
Plan and at such times and under such conditions as determined by the Administrator and set forth in the Award Agreement. An Option may not be exercised for a fraction of a Share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">An Option will be deemed exercised when the Company receives: (a)&nbsp;notice of exercise (in such form as the Administrator may specify from
time to time) from the person entitled to exercise the Option, and (b)&nbsp;full payment for the Shares with respect to which the Option is exercised (together with applicable tax withholding). Full payment may consist of any consideration and
method of payment authorized by the Administrator and permitted by the Award Agreement and the Plan. Shares issued upon exercise of an Option will be issued in the name of the Participant or, if requested by the Participant, in the name of the
Participant and his or her spouse. Until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a
stockholder will exist with respect to the Shares subject to an Option, notwithstanding the exercise of the Option. The Company will issue (or cause to be issued) such Shares promptly after the Option is exercised. No adjustment will be made for a
dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section&nbsp;14<B> </B>of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Exercising an Option in any manner will decrease the number of Shares thereafter available, both for purposes of the Plan and for sale under
the Option, by the number of Shares as to which the Option is exercised. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">6.6.2 <U>Termination of Relationship as a Service Provider</U>.
If a Participant ceases to be a Service Provider, other than upon the Participant&#8217;s termination as the result of the Participant&#8217;s death or Disability, the Participant may exercise his or her Option, to the extent that the Option is
vested on the date of termination, within three (3)&nbsp;months of termination, or such shorter or longer period of time, as is specified in the Award Agreement or in writing by the Administrator, in each case, in no event later than the expiration
of the term of such Option as set forth in the Award Agreement. Unless otherwise provided by the Administrator, if on the date of termination the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of
the Option will revert to the Plan. If after termination the Participant does not exercise his or her Option within the time specified by the Administrator, the Option will terminate, and the Shares covered by such Option will revert to the Plan.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-10- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">6.6.3 <U>Disability of Participant</U>. If a Participant ceases to be a Service Provider as
a result of the Participant&#8217;s Disability, the Participant may exercise his or her Option within twelve (12)&nbsp;months of termination, or such longer or shorter period of time as is specified in the Award Agreement or in writing by the
Administrator (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement) to the extent the Option is vested on the date of termination. Unless otherwise provided by the Administrator, if on the date of
termination the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option will revert to the Plan. If after termination the Participant does not exercise his or her Option within the time
specified herein, the Option will terminate, and the Shares covered by such Option will revert to the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">6.6.4 <U>Death of
Participant</U>. If a Participant dies while a Service Provider, the Option may be exercised within twelve (12)&nbsp;months following the Participant&#8217;s death, or within such longer or shorter period of time as is specified in the Award
Agreement or in writing by the Administrator (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement) to the extent that the Option is vested on the date of death, by the Participant&#8217;s
designated beneficiary, provided such beneficiary has been designated prior to the Participant&#8217;s death in a form (if any) acceptable to the Administrator. If no such beneficiary has been designated by the Participant, then such Option may be
exercised by the personal representative of the Participant&#8217;s estate or by the person(s) to whom the Option is transferred pursuant to the Participant&#8217;s will or in accordance with the laws of descent and distribution (each, a
&#8220;<U>Legal Representative</U>&#8221;). If the Option is exercised pursuant to this Section&nbsp;6.6.4, Participant&#8217;s designated beneficiary or Legal Representative shall be subject to the terms of this Plan and the Award Agreement,
including but not limited to the restrictions on transferability and forfeitability applicable to the Service Provider. Unless otherwise provided by the Administrator, if at the time of death Participant is not vested as to his or her entire Option,
the Shares covered by the unvested portion of the Option will immediately revert to the Plan. If the Option is not so exercised within the time specified herein, the Option will terminate, and the Shares covered by such Option will revert to the
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">6.6.5 <U>Tolling Expiration</U>. A Participant&#8217;s Award Agreement may also provide that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(a) if the exercise of the Option following the cessation of Participant&#8217;s status as a Service Provider (other than upon the
Participant&#8217;s death or Disability) would result in liability under Section&nbsp;16(b), then the Option will terminate on the earlier of (i)&nbsp;the expiration of the term of the Option set forth in the Award Agreement, or (ii)&nbsp;the tenth
(10<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) day after the last date on which such exercise would result in liability under Section&nbsp;16(b); or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(b) if the exercise of the Option following the cessation of the Participant&#8217;s status as a Service Provider (other than upon the
Participant&#8217;s death or Disability) would be prohibited at any time solely because the issuance of Shares would violate the registration requirements under the Securities Act, then the Option will terminate on the earlier of (i)&nbsp;the
expiration of the term of the Option or (ii)&nbsp;the expiration of a period of thirty (30)&nbsp;days after the cessation of the Participant&#8217;s status as a Service Provider during which the exercise of the Option would not be in violation of
such registration requirements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-11- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Stock Appreciation Rights</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.1 <U>Grant of Stock Appreciation Rights</U>. Subject to the terms and conditions of the Plan, a Stock Appreciation Right may be granted to
Service Providers at any time and from time to time as will be determined by the Administrator, in its sole discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.2 <U>Number of
Shares</U>. The Administrator will have complete discretion to determine the number of Shares subject to any Award of Stock Appreciation Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.3 <U>Exercise Price and Other Terms</U>. The per Share exercise price for the Shares that will determine the amount of the payment to be
received upon exercise of a Stock Appreciation Right as set forth in Section&nbsp;7.6 will be determined by the Administrator and will be no less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant. Otherwise, the
Administrator, subject to the provisions of the Plan, will have complete discretion to determine the terms and conditions of Stock Appreciation Rights granted under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.4 <U>Stock Appreciation Right Agreement</U>. Each Stock Appreciation Right grant will be evidenced by an Award Agreement that will specify
the exercise price, the term of the Stock Appreciation Right, the conditions of exercise, and such other terms and conditions as the Administrator, in its sole discretion, will determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.5 <U>Expiration of Stock Appreciation Rights</U>. A Stock Appreciation Right granted under the Plan will expire upon the date determined by
the Administrator, in its sole discretion, and set forth in the Award Agreement. Notwithstanding the foregoing, the rules of Section&nbsp;6.4 relating to the maximum term and Section&nbsp;6.5 relating to exercise also will apply to Stock
Appreciation Rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.6 <U>Payment of Stock Appreciation Right Amount</U>. Upon exercise of a Stock Appreciation Right, a Participant
will be entitled to receive payment from the Company in an amount determined by multiplying: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">7.6.1 The difference between the Fair
Market Value of a Share on the date of exercise over the exercise price; times </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">7.6.2 The number of Shares with respect to which the
Stock Appreciation Right is exercised. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">At the discretion of the Administrator, the payment upon Stock Appreciation Right exercise may be
in cash, in Shares of equivalent value, or in some combination thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Restricted Stock</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.1 <U>Grant of Restricted Stock</U>. Subject to the terms and provisions of the Plan, the Administrator, at any time and from time to time,
may grant Shares of Restricted Stock to Service Providers in such amounts as the Administrator, in its sole discretion, will determine. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-12- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.2 <U>Restricted Stock Agreement</U>. Each Award of Restricted Stock will be evidenced by
an Award Agreement that will specify the Period of Restriction (if any), the number of Shares granted, and such other terms and conditions as the Administrator, in its sole discretion, will determine. Unless the Administrator determines otherwise,
the Company as escrow agent will hold Shares of Restricted Stock until the restrictions on such Shares have lapsed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3
<U>Transferability</U>. Except as provided in this Section&nbsp;8 or as the Administrator determines, Shares of Restricted Stock may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated until the end of the applicable
Period of Restriction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.4 <U>Other Restrictions</U>. The Administrator, in its sole discretion, may impose such other restrictions on
Shares of Restricted Stock as it may deem advisable or appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.5 <U>Removal of Restrictions</U>. Except as otherwise provided in
this Section&nbsp;8, Shares of Restricted Stock covered by each Restricted Stock grant made under the Plan will be released from escrow as soon as practicable after the last day of the Period of Restriction or at such other time as the Administrator
may determine. The Administrator, in its discretion, may accelerate the time at which any restrictions will lapse or be removed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.6
<U>Voting Rights</U>. During the Period of Restriction, Service Providers holding Shares of Restricted Stock granted hereunder may exercise full voting rights with respect to those Shares, unless the Administrator determines otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.7 <U>Return of Restricted Stock to Company</U>. On the date set forth in the Award Agreement, the Restricted Stock for which restrictions
have not lapsed will revert to the Company and again will become available for grant under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Restricted Stock Units</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.1 <U>Grant</U>. Restricted Stock Units may be granted at any time and from time to time as determined by the Administrator. After the
Administrator determines that it will grant Restricted Stock Units, it will advise the Participant in an Award Agreement of the terms, conditions, and restrictions related to the grant, including the number of Restricted Stock Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2 <U>Vesting Criteria and Other Terms</U>. The Administrator will set vesting criteria in its discretion, which, depending on the extent to
which the criteria are met, will determine the number of Restricted Stock Units that will be paid out to the Participant. The Administrator may set vesting criteria based upon the achievement of Company-wide, divisional, business unit, or individual
goals (including, but not limited to, continued employment or service), applicable federal or state securities laws or any other basis determined by the Administrator in its discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.3 <U>Earning Restricted Stock Units</U>. Upon meeting the applicable vesting criteria, the Participant will be entitled to receive a payout
as determined by the Administrator. Notwithstanding the foregoing, at any time after the grant of Restricted Stock Units, the Administrator, in its sole discretion, may reduce or waive any vesting criteria that must be met to receive a payout. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-13- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.4 <U>Form and Timing of Payment</U>. Payment of earned Restricted Stock Units will be made
at the time(s) determined by the Administrator and set forth in the Award Agreement. The Administrator, in its sole discretion, may settle earned Restricted Stock Units in cash, Shares, or a combination of both. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.5 <U>Cancellation</U>. On the date set forth in the Award Agreement, all unearned Restricted Stock Units will be forfeited to the Company.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Performance Awards</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.1 <U>Award Agreement</U>. Each Performance Award will be evidenced by an Award Agreement that will specify any time period during which any
performance objectives or other vesting provisions will be measured (&#8220;<U>Performance Period</U>&#8221;), and such other terms and conditions as the Administrator determines. Each Performance Award will have an initial value that is determined
by the Administrator on or before its date of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.2 <U>Objectives or Vesting Provisions and Other Terms</U>. The Administrator will
set any objectives or vesting provisions that, depending on the extent to which any such objectives or vesting provisions are met, will determine the value of the payout for the Performance Awards. The Administrator may set vesting criteria based
upon the achievement of Company-wide, divisional, business unit, or individual goals (including, but not limited to, continued employment or service), applicable federal or state securities laws,&nbsp;or any other basis determined by the
Administrator in its discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.3 <U>Earning Performance Awards</U>. After an applicable Performance Period has ended, the holder of
a Performance Award will be entitled to receive a payout for the Performance Award earned by the Participant over the Performance Period. The Administrator, in its discretion, may reduce or waive any performance objectives or other vesting
provisions for such Performance Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.4 <U>Form and Timing of Payment</U>. Payment of earned Performance Awards will be made at the
time(s) determined by the Administrator and set forth in the Award Agreement. The Administrator, in its sole discretion, may settle earned Performance Awards in cash, Shares, or a combination of both. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.5 <U>Cancellation of Performance Awards</U>. On the date set forth in the Award Agreement, all unearned or unvested Performance Awards will
be forfeited to the Company, and again will be available for grant under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Compliance With
Section</U><U></U><U>&nbsp;409A</U>. Awards will be designed and operated in such a manner that they are either exempt from the application of, or comply with, the requirements of Section&nbsp;409A such that the grant, payment, settlement or
deferral will not be subject to the additional tax or interest applicable under Section&nbsp;409A, except as otherwise determined in the sole discretion of the Administrator. The Plan and each Award Agreement under the Plan is intended to be exempt
from or meet the&nbsp;requirements of Section&nbsp;409A and will be construed and interpreted in accordance with such intent (including with respect to any ambiguities or ambiguous terms), except as otherwise determined in the sole discretion of the
Administrator. To the extent that an Award or payment, or the settlement or deferral thereof, is subject to Section&nbsp;409A the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-14- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Award will be granted, paid, settled or deferred in a manner that will meet the requirements of Section&nbsp;409A, such that the grant, payment, settlement or deferral will not be subject to the
additional tax or interest applicable under Section&nbsp;409A. In no event will the Company or any of its Parent or Subsidiaries have any responsibility, liability, or obligation to reimburse, indemnify, or hold harmless a Participant (or any other
person) in respect of Awards, for any taxes, penalties or interest that may be imposed on, or other costs incurred by, Participant (or any other person) as a result of Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Leaves of Absence/Transfer Between Locations</U>. Unless the Administrator provides otherwise or as otherwise required by Applicable
Laws, vesting of Awards granted hereunder will be suspended during any unpaid leave of absence. A Participant will not cease to be an Employee in the case of (a)&nbsp;any leave of absence approved by the Company or (b)&nbsp;transfers between
locations of the Company or between the Company, its Parent, or any of its Subsidiaries. For purposes of Incentive Stock Options, no such leave may exceed three (3)&nbsp;months, unless reemployment upon expiration of such leave is guaranteed by
statute or contract. If reemployment upon expiration of a leave of absence approved by the Company is not so guaranteed, then six (6)&nbsp;months following the first (1<SUP STYLE="font-size:75%; vertical-align:top">st</SUP>) day of such leave, any
Incentive Stock Option held by the Participant will cease to be treated as an Incentive Stock Option and will be treated for tax purposes as a Nonstatutory Stock Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Limited Transferability of Awards</U>. Unless determined otherwise by the Administrator, Awards may not be sold, pledged, assigned,
hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent and distribution (which, for purposes of clarification, shall be deemed to include through a beneficiary designation if available in accordance with
Section&nbsp;6.6), and may be exercised, during the lifetime of the Participant, only by the Participant. If the Administrator makes an Award transferable, such Award will contain such additional terms and conditions as the Administrator deems
appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Adjustments; Dissolution or Liquidation; Merger or Change in Control</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14.1 <U>Adjustments</U>. In the event that any extraordinary dividend or other distribution (whether in the form of cash, Shares, other
securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, <FONT STYLE="white-space:nowrap">split-up,</FONT> <FONT STYLE="white-space:nowrap">spin-off,</FONT> combination,
reclassification, repurchase, or exchange of Shares or other securities of the Company, or other change in the corporate structure of the Company affecting the Shares occurs (other than any ordinary dividends or other ordinary distributions), the
Administrator, in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made available under the Plan, will adjust the number and class of shares of stock that may be delivered under the Plan and/or the
number, class, and price of shares of stock covered by each outstanding Award, and numerical Share limits in Section&nbsp;3. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14.2
<U>Dissolution or Liquidation</U>. In the event of the proposed dissolution or liquidation of the Company, the Administrator will notify each Participant as soon as practicable prior to the effective date of such proposed transaction. To the extent
it has not been previously exercised, an Award will terminate immediately prior to the consummation of such proposed action. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-15- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14.3 <U>Merger or Change in Control</U>. In the event of a merger of the Company with or
into another corporation or other entity or a Change in Control, each outstanding Award will be treated as the Administrator determines (subject to the provisions of the following paragraph) without a Participant&#8217;s consent, including, without
limitation, that (a)&nbsp;Awards will be assumed, or substantially equivalent awards will be substituted, by the acquiring or succeeding corporation (or an affiliate thereof) with appropriate adjustments as to the number and kind of shares and
prices; (b)&nbsp;upon written notice to a Participant, that the Participant&#8217;s Awards will terminate upon or immediately prior to the consummation of such merger or Change in Control; (c)&nbsp;outstanding Awards will vest and become
exercisable, realizable, or payable, or restrictions applicable to an Award will lapse, in whole or in part prior to or upon consummation of such merger or Change in Control, and, to the extent the Administrator determines, terminate upon or
immediately prior to the effectiveness of such merger or Change in Control; (d)&nbsp;(i) the termination of an Award in exchange for an amount of cash and/or property, if any, equal to the amount that would have been attained upon the exercise of
such Award or realization of the Participant&#8217;s rights as of the date of the occurrence of the transaction (and, for the avoidance of doubt, if as of the date of the occurrence of the transaction the Administrator determines in good faith that
no amount would have been attained upon the exercise of such Award or realization of the Participant&#8217;s rights, then such Award may be terminated by the Company without payment), or (ii)&nbsp;the replacement of such Award with other rights or
property selected by the Administrator in its sole discretion; or (e)&nbsp;any combination of the foregoing. In taking any of the actions permitted under this Section&nbsp;14.3, the Administrator will not be obligated to treat all Awards, all Awards
held by a Participant, all Awards of the same type, or all portions of Awards, similarly. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In the event that the successor corporation
does not assume or substitute for the Award (or portion thereof), the Participant will fully vest in and have the right to exercise his or her outstanding Options and Stock Appreciation Rights (or portions thereof) not assumed or substituted for,
including Shares as to which such Awards would not otherwise be vested or exercisable, all restrictions on Restricted Stock, Restricted Stock Units, Performance Shares and Performance Units (or portions thereof) not assumed or substituted for will
lapse, and, with respect to Awards with performance-based vesting (or portions thereof) not assumed or substituted for, all performance goals or other vesting criteria will be deemed achieved at one hundred percent (100%) of target levels and all
other terms and conditions met, in each case, unless specifically provided otherwise under the applicable Award Agreement or other written agreement between the Participant and the Company or any of its Subsidiaries or Parents, as applicable. In
addition, unless specifically provided otherwise under the applicable Award Agreement or other written agreement between the Participant and the Company or any of its Subsidiaries or Parents, as applicable, if an Option or Stock Appreciation Right
(or portion thereof) is not assumed or substituted in the event of a merger or Change in Control, the Administrator will notify the Participant in writing or electronically that the Option or Stock Appreciation Right (or its applicable portion) will
be exercisable for a period of time determined by the Administrator in its sole discretion, and the Option or Stock Appreciation Right (or its applicable portion) will terminate upon the expiration of such period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-16- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the purposes of this Section&nbsp;14.3 and Section&nbsp;14.4 below, an Award will be
considered assumed if, following the merger or Change in Control, the Award confers the right to purchase or receive, for each Share subject to the Award immediately prior to the merger or Change in Control, the consideration (whether stock, cash,
or other securities or property) received in the merger or Change in Control by holders of Common Stock for each Share held on the effective date of the transaction (and if holders were offered a choice of consideration, the type of consideration
chosen by the holders of a majority of the outstanding Shares); provided, however, that if such consideration received in the merger or Change in Control is not solely common stock of the successor corporation or its Parent, the Administrator may,
with the consent of the successor corporation, provide for the consideration to be received upon the exercise of an Option or Stock Appreciation Right or upon the payout of a Restricted Stock Unit, Performance Unit or Performance Share, for each
Share subject to such Award, to be solely common stock of the successor corporation or its Parent equal in fair market value to the per share consideration received by holders of Common Stock in the merger or Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in this Section&nbsp;14.3 to the contrary, an Award that vests, is earned or
<FONT STYLE="white-space:nowrap">paid-out</FONT> upon the satisfaction of one or more performance goals will not be considered assumed if the Company or its successor modifies any of such performance goals without the Participant&#8217;s consent, in
all cases, unless specifically provided otherwise under the applicable Award Agreement or other written agreement between the Participant and the Company or any of its Subsidiaries or Parents, as applicable; provided, however, a modification to such
performance goals only to reflect the successor corporation&#8217;s post-Change in Control corporate structure will not be deemed to invalidate an otherwise valid Award assumption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in this Section&nbsp;14.3 to the contrary, and unless otherwise provided in an Award Agreement, if an Award that
vests, is earned or <FONT STYLE="white-space:nowrap">paid-out</FONT> under an Award Agreement is subject to Section&nbsp;409A and if the change in control definition contained in the Award Agreement (or other agreement related to the Award, as
applicable) does not comply with the definition of &#8220;change in control&#8221; for purposes of a distribution under Section&nbsp;409A, then any payment of an amount that is otherwise accelerated under this Section will be delayed until the
earliest time that such payment would be permissible under Section&nbsp;409A without triggering any penalties applicable under Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14.4 <U>Outside Director Awards</U>. With respect to Awards granted to an Outside Director, the Outside Director will fully vest in and have
the right to exercise Options and/or Stock Appreciation Rights as to all of the Shares underlying such Award, including those Shares which otherwise would not be vested or exercisable, all restrictions on Restricted Stock and Restricted Stock Units
will lapse, and, with respect to Awards with performance-based vesting, all performance goals or other vesting criteria will be deemed achieved at one hundred percent (100%) of target levels and all other terms and conditions met, unless
specifically provided otherwise under the applicable Award Agreement or other written agreement between the Participant and the Company or any of its Parent or Subsidiaries, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Award</U><U> Limitations</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Outside Director Award Limitations</U>. No Outside Director may be paid, issued, or granted, in any Fiscal Year, equity awards
(including any Awards issued under this Plan) with an aggregate value (the value of which will be based on their grant date fair value determined in accordance with U.S. generally accepted accounting principles) and any other compensation (including
without limitation any cash retainers or fees) that, in the aggregate, exceed $750,000, increased to $1,000,000 for such Outside Director for the Fiscal Year in which he or she joins the Board as an Outside Director. Any Awards or other compensation
paid or provided to an individual for his or her services as an Employee, or for his or her services as a Consultant (other than as an Outside Director), will not count for purposes of the limitation under this Section&nbsp;15(a). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-17- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Dividends and Other Distributions</U>. Service Providers holding Awards granted under
the Plan will not be entitled to receive any dividends or other distributions paid with respect to Shares underlying any such Award until such Award has fully vested, and all Periods of Restriction with respect to such Award has lapsed, and Shares
have been issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) pursuant to such Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Tax Withholding</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">16.1 <U>Withholding Requirements</U>. Prior to the delivery of any Shares or cash pursuant to an Award (or exercise thereof) or such earlier
time as any tax withholdings are due, the Company (or any of its Parent, Subsidiaries, or affiliates employing or retaining the services of a Participant, as applicable) will have the power and the right to deduct or withhold, or require a
Participant to remit to the Company (or any of its Parent, Subsidiaries, or affiliates, as applicable) or a relevant tax authority, an amount sufficient to satisfy U.S. federal, state, local, <FONT STYLE="white-space:nowrap">non-U.S.,</FONT> and
other taxes (including the Participant&#8217;s FICA obligation) required to be withheld or paid with respect to such Award (or exercise thereof). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">16.2 <U>Withholding Arrangements</U>. The Administrator, in its sole discretion and pursuant to such procedures as it may specify from time to
time, may permit a Participant to satisfy such tax liability or withholding obligation, in whole or in part by such methods as the Administrator shall determine, including, without limitation, (a)&nbsp;paying cash, (b)&nbsp;electing to have the
Company withhold otherwise deliverable cash or Shares having a fair market value equal to the minimum statutory amount required to be withheld or such greater amount as the Administrator may determine if such amount would not have adverse accounting
consequences, as the Administrator determines in its sole discretion, (c)&nbsp;delivering to the Company already-owned Shares having a fair market value equal to the statutory amount required to be withheld or such greater amount as the
Administrator may determine, in each case, provided the delivery of such Shares will not result in any adverse accounting consequences, as the Administrator determines in its sole discretion, (d)&nbsp;selling a sufficient number of Shares otherwise
deliverable to the Participant through such means as the Administrator may determine in its sole discretion (whether through a broker or otherwise) equal to the amount required to be withheld or paid, (e)&nbsp;such other consideration and method of
payment for the meeting of tax liabilities or withholding obligations as the Administrator may determine to the extent permitted by Applicable Laws, or (f)&nbsp;any combination of the foregoing methods of payment. The amount of the withholding
requirement will be deemed to include any amount which the Administrator agrees may be withheld at the time the election is made, not to exceed the amount determined by using the maximum federal, state or local marginal income tax rates applicable
to the Participant with respect to the Award on the date that the amount of tax to be withheld is to be determined or such greater amount as the Administrator may determine if such amount would not have adverse accounting consequences, as the
Administrator determines in its sole discretion. The fair market value of the Shares to be withheld or delivered will be determined as of the date that the taxes are required to be withheld. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-18- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>No Effect on Employment or Service</U>. Neither the Plan nor any Award will confer
upon a Participant any right with respect to continuing the Participant&#8217;s relationship as a Service Provider with the Company or its Subsidiaries or Parents, as applicable, nor will they interfere in any way with the Participant&#8217;s right
or the right of the Company and its Subsidiaries or Parents, as applicable, to terminate such relationship at any time, with or without cause, to the extent permitted by Applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>Date of Grant</U>. The date of grant of an Award will be, for all purposes, the date on which the Administrator makes the determination
granting such Award, or such other later date as is determined by the Administrator. Notice of the determination will be provided to each Participant within a reasonable time after the date of such grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>Term of Plan</U>. Subject to Section&nbsp;23 of the Plan, the Plan will become effective as of its adoption by the Board. The Plan will
continue in effect until terminated under Section&nbsp;20, but no Options that qualify as incentive stock options within the meaning of Code Section&nbsp;422 may be granted after April&nbsp;28, 2036, which is ten (10)&nbsp;years from the earlier of
the Board or stockholder approval of the Plan, as most recently amended and restated in 2026. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <U>Amendment and Termination of the
Plan</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">20.1 <U>Amendment and Termination</U>. The Administrator may at any time amend, alter, suspend or terminate the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">20.2 <U>Stockholder Approval</U>. The Company will obtain stockholder approval of any Plan amendment to the extent necessary and desirable to
comply with Applicable Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">20.3 <U>Effect of Amendment or Termination</U>. No amendment, alteration, suspension or termination of the
Plan will materially impair the rights of any Participant, unless mutually agreed otherwise between the Participant and the Administrator, which agreement must be in writing and signed by the Participant and the Company. Termination of the Plan will
not affect the Administrator&#8217;s ability to exercise the powers granted to it hereunder with respect to Awards granted under the Plan prior to the date of such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <U>Conditions Upon Issuance of Shares</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">21.1 <U>Legal Compliance</U>. Shares will not be issued pursuant to the exercise of an Award unless the exercise of such Award and the
issuance and delivery of such Shares will comply with Applicable Laws and will be further subject to the approval of counsel for the Company with respect to such compliance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">21.2 <U>Investment Representations</U>. As a condition to the exercise of an Award, the Company may require the person exercising such Award
to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a
representation is required. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-19- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. <U>Inability to Obtain Authority</U>. The inability of the Company to obtain authority
from any regulatory body having jurisdiction or to complete or comply with the requirements of any registration or other qualification of the Shares under any U.S. state or federal law or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> law or under
the rules and regulations of the Securities and Exchange Commission, the stock exchange on which Shares of the same class are then listed, or any other governmental or regulatory body, which authority, registration, qualification or rule compliance
is deemed by the Company&#8217;s counsel to be necessary or advisable for the issuance and sale of any Shares hereunder, will relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite
authority, registration, qualification or rule compliance will not have been obtained. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23. <U>Stockholder Approval</U>. The Plan will be
subject to approval by the stockholders of the Company within twelve (12)&nbsp;months after the date the Plan is adopted by the Board. Such stockholder approval will be obtained in the manner and to the degree required under Applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24. <U>Forfeiture Events</U>. The Administrator may specify in an Award Agreement that the Participant&#8217;s rights, payments, and benefits
with respect to an Award will be subject to the reduction, cancellation, forfeiture, recoupment, reimbursement, or reacquisition upon the occurrence of certain specified events, in addition to any otherwise applicable vesting or performance
conditions of an Award. Notwithstanding any provisions to the contrary under this Plan, an Award shall be subject to the Company&#8217;s clawback policy as may be established and/or amended from time to time to comply with Applicable Laws (including
without limitation pursuant to the listing standards of any national securities exchange or association on which the Company&#8217;s securities are listed or as may be required by the <FONT STYLE="white-space:nowrap">Dodd-Frank</FONT> Wall Street
Reform and Consumer Protection Act) (the &#8220;<U>Clawback</U><U> Policy</U>&#8221;). The Administrator may require a Participant to forfeit, return or reimburse the Company all or a portion of the Award and any amounts paid thereunder pursuant to
the terms of the Clawback Policy or as necessary or appropriate to comply with Applicable Laws. Unless this Section&nbsp;24 specifically is mentioned and waived in an Award Agreement or other document, no recovery of compensation under a Clawback
Policy or otherwise will constitute an event that triggers or contributes to any right of a Participant to resign for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or similar term) under any agreement with the Company or any
Parent or Subsidiary of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">* * * </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-20- </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>fbrx-20260529.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2606 Build:20260317.3 -->
<!-- Creation date: 6/2/2026 11:40:31 PM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2025"
  xmlns:fbrx="http://www.fortebiorx.com/20260529"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2025"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.fortebiorx.com/20260529"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" namespace="http://xbrl.sec.gov/naics/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" namespace="http://fasb.org/srt/2025" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" namespace="http://xbrl.sec.gov/stpr/2025" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fbrx-20260529_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fbrx-20260529_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>fbrx-20260529_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2606 Build:20260317.3 -->
<!-- Creation date: 6/2/2026 11:40:31 PM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>fbrx-20260529_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2606 Build:20260317.3 -->
<!-- Creation date: 6/2/2026 11:40:31 PM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="fbrx-20260529.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 29, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001419041<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 29,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FORTE BIOSCIENCES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-1243872<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3060 Pegasus Park Dr.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building 6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dallas<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(310)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">618-6994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FBRX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d110060d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d110060d8k.htm">d110060d8k.htm</File>
    <File>fbrx-20260529.xsd</File>
    <File>fbrx-20260529_lab.xml</File>
    <File>fbrx-20260529_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d110060d8k.htm": {
   "nsprefix": "fbrx",
   "nsuri": "http://www.fortebiorx.com/20260529",
   "dts": {
    "inline": {
     "local": [
      "d110060d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "fbrx-20260529.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "fbrx-20260529_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fbrx-20260529_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2026-05-29_to_2026-05-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d110060d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2026-05-29_to_2026-05-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d110060d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.fortebiorx.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001193125-26-253436-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-26-253436-xbrl.zip
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M++R-&S+AYTVCN&(!48MQA^&RM@:T]6"Y],^KULVD>;"X_:1I-N"6)P -?2L
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M;,;D8*@HU,6-&,((($YT3@L?^^C)5M;K[P,6[NU&PJ.=COSZPKV3$U6Z=[)
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M7?HF>8IS+RRSV>\!++Q$7,\L*/5^$8D7G5^XL$B/R]NV#1#3,]VA0T,W,KT
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M[1Z(Y X%G)CRK>K9)D[B\V!=3=Y*]$".1Q.^)68E;&+T>[O^\(WWQQ\YZ*K
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M3[W\_I#O?9>$#:+J?%R^6ZRRP?/]<K68S_,I>A++RR$9ZQ,(#DVC]JZP@?Y
MV;DQ7#>D>\HW/ :QA?1V9%F_Q'>B9R+4,PFIKFQK0R_$Z&\.$/7LNM/9RK8-
M<$K<IQJ(9RHB-;04FRCEG[=Q9U2R%?$J><K'*@_1=L*%N2ZUP>#V7D;;]V)W
M.Q$*@P1HI"@VR2S8$;A5*.RU8;FN7KE.IG,LO]#O1=E^-AYM[>V^^O*KW6VW
M<T\?PT8BN0/_*>^3*?D"B.#>Z^[LU0-XXO4V];YQKNHR:SO1!2J56N(V]?IK
M]Q*'?6.?\?4I\N0&%#DD7/]XJN3,Z+/BA(2.+@?$+!D"%Y<(Q%DT-X3?<E[4
MI?']-]@VIK,I- H_T8%O^>WX;DCMJ"A=@=Q[Q.P_E6DU_*QH@,*V'IJ4?R#:
M5E'MS?>NUPUZ@&9X>25&#>3/"VU\ABWW;!Y8[Q\X%V5O[Z=O[59+FI^JDN9(
M6?B&.A8]#<J;UXQOL.!998EX!<\K>D+T2M:QIBPL:5Y;':WQG[^S1]K=%YX\
MY9C<!Q-#A)D3+U^9+DPIIH0>!]/4?8?7XTAZX?%+5T8]N-L;H<2'_2(7VG.&
MQ,4 9OL=12^V[CM(8>:FWP'D"_FO,=M0TD[[62##]!SZ:/PFGSM/KDJF'MC'
M'UY*\]'8GVG$8=V#OQW"-;@F@0[QC>%N./W68!MJ'_N4':"#5!"#+1B\F>M0
MOAO"@"WX=1@&0U_G._T-<&UQ*)'O#\<AN..M>\P<1BN=:P3>P9K-ZY&D25BB
MIFTV_X$.G7?N>>^NN'17RZI<6:S%N\UH@CAMWR/WJ(=#V$,/#2N[O"<L#9)G
M@MLZ+!8,(T,+"(QE2,K<K>"EC.!/#N%K^""3@& JN$:KJ[170FQ.MTK--,EP
M-O?2I'&JR@-T6K*,\N7%G!LC()+BB[MW8CVE#&84P*:O HC<D[R[R,5\1 DT
M'H55^EE<!KDE/9<CY#.SEY*2O)%I[M,T>[K48&*L=*:+T=*&D\"DQD])Y#J"
M>)QZFA"QKL$)V6TR@1)I,Y6Z#F^TO[9,"]OD+O-4PA0MMB/292F=J=F_:Z"I
M9V25A?A;&S+&G@7&6'Q8=P,ZA=UC!=11;6@/J.RN<*A^2!?*_D\7RBV?C_W8
M:8WJW-;&[=T=4[?'HRM#AGVR/LK/"MG>A*H'H,(\.)D_5JW^U?7M'*S"M$%'
M"0*JKM)8^8YHJ:<V1QT3\5>Q@*4M0@@CI;T"V9(ZR-Z]VO=LYR$0]J^OC_W0
MK9!+-"V^'[=^1A4+JU<V7;50JM8)FVJG.M"/G0+SZ2F12(M!<&D"[,+#<.QR
M#HUC-/=R@5<FTF3>; "5#C#KUQ#:49+=Q"X\<KV/U$B&W%[#-(\K6<P)K5P=
MIH#\C%,MNA>8X<,N2*SF4K"V?D.'32S28^9Q<],@O+]2CF(CV0-%A6>Z1[PK
M*3/L,-.[@?4 *E49: 4/UF!.K2)(E3!<!/>NEDY66,W'.1&]X..E55BBS!7W
MI//8ICA^>T>1M1;%#8>)*J0GV^(D=PD)R/])O0\:F8C+F=@9][N&J[!AF^%M
M3XBW_<8P--IY<>B:+T87-HWH;@8!?06U](M/O<Q<JBH44!PIZ^I7;N'1-:@*
MR^M(K(VHY4_Y2&*SYB$M6$2H-'%39N[Z&#_^V'NE*_G2=#<>D1RE+"7NQAY)
M#O4@!$^SPA[22!?8>'ODN[;"GD>M,(8VWA#N[W-EB_&F#O2_#L)85PI8K8D
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MWRB0SY4I80%8DE?PX0E@M64;$,/[!LG=9BE1+[EW+7JI)PJ<:T/!+QC?'D/
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MTB#EV/[V(_70R#$E4^&IRHNVLG3WO_O+OU,9R<[[CYM%! ]$2,K9<:??/>H
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MV#?[*">6_ U02P$"% ,4    "  FH,)<5.OT?, 6   OL   #@
M    @ $     9#$Q,# V,&0X:RYH=&U02P$"% ,4    "  FH,)</0EAQ,=(
M  #T<P$ $0              @ 'L%@  9#$Q,# V,&1E>#$P,2YH=&U02P$"
M% ,4    "  FH,)<?2-*CFL#  "=#   $0              @ 'B7P  9F)R
M>"TR,#(V,#4R.2YX<V102P$"% ,4    "  FH,)<7Y"J"WH&  "W1@  %0
M            @ %\8P  9F)R>"TR,#(V,#4R.5]L86(N>&UL4$L! A0#%
M  @ )J#"7/]^$&+$!   02P  !4              ( !*6H  &9B<G@M,C R
C-C U,CE?<')E+GAM;%!+!08     !0 % $ !   @;P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>d110060d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="fbrx-20260529.xsd" xlink:type="simple"/>
    <context id="duration_2026-05-29_to_2026-05-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001419041</identifier>
        </entity>
        <period>
            <startDate>2026-05-29</startDate>
            <endDate>2026-05-29</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-486">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2026-05-29_to_2026-05-29"
      id="Hidden_dei_EntityCentralIndexKey">0001419041</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-497">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-498">2026-05-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-499">FORTE BIOSCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-500">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-501">001-38052</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-502">26-1243872</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-503">3060 Pegasus Park Dr.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-504">Building 6</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-505">Dallas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-506">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-507">75247</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-508">(310)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-509">618-6994</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-510">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-511">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-512">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-513">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-514">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-515">FBRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-516">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-517">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
